50% OFF
MarketBeat All Access
Get 30 days free. Save 50% your first year.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
×
S&P 500   3,629.71 (-2.40%)
DOW   29,128.46 (-1.87%)
QQQ   271.09 (-3.16%)
AAPL   142.56 (-4.86%)
MSFT   235.85 (-2.17%)
META   137.50 (-2.90%)
GOOGL   96.56 (-3.49%)
AMZN   114.49 (-2.98%)
TSLA   268.44 (-6.73%)
NVDA   120.84 (-5.12%)
NIO   15.61 (-9.92%)
BABA   78.29 (-3.33%)
AMD   63.88 (-6.55%)
T   15.51 (-2.02%)
MU   49.87 (-2.22%)
CGC   2.82 (-7.24%)
F   11.47 (-5.83%)
GE   62.35 (-3.27%)
DIS   97.07 (-2.34%)
AMC   7.09 (-7.56%)
PYPL   89.01 (-2.32%)
PFE   44.26 (-0.38%)
NFLX   239.03 (-2.52%)
S&P 500   3,629.71 (-2.40%)
DOW   29,128.46 (-1.87%)
QQQ   271.09 (-3.16%)
AAPL   142.56 (-4.86%)
MSFT   235.85 (-2.17%)
META   137.50 (-2.90%)
GOOGL   96.56 (-3.49%)
AMZN   114.49 (-2.98%)
TSLA   268.44 (-6.73%)
NVDA   120.84 (-5.12%)
NIO   15.61 (-9.92%)
BABA   78.29 (-3.33%)
AMD   63.88 (-6.55%)
T   15.51 (-2.02%)
MU   49.87 (-2.22%)
CGC   2.82 (-7.24%)
F   11.47 (-5.83%)
GE   62.35 (-3.27%)
DIS   97.07 (-2.34%)
AMC   7.09 (-7.56%)
PYPL   89.01 (-2.32%)
PFE   44.26 (-0.38%)
NFLX   239.03 (-2.52%)
S&P 500   3,629.71 (-2.40%)
DOW   29,128.46 (-1.87%)
QQQ   271.09 (-3.16%)
AAPL   142.56 (-4.86%)
MSFT   235.85 (-2.17%)
META   137.50 (-2.90%)
GOOGL   96.56 (-3.49%)
AMZN   114.49 (-2.98%)
TSLA   268.44 (-6.73%)
NVDA   120.84 (-5.12%)
NIO   15.61 (-9.92%)
BABA   78.29 (-3.33%)
AMD   63.88 (-6.55%)
T   15.51 (-2.02%)
MU   49.87 (-2.22%)
CGC   2.82 (-7.24%)
F   11.47 (-5.83%)
GE   62.35 (-3.27%)
DIS   97.07 (-2.34%)
AMC   7.09 (-7.56%)
PYPL   89.01 (-2.32%)
PFE   44.26 (-0.38%)
NFLX   239.03 (-2.52%)
S&P 500   3,629.71 (-2.40%)
DOW   29,128.46 (-1.87%)
QQQ   271.09 (-3.16%)
AAPL   142.56 (-4.86%)
MSFT   235.85 (-2.17%)
META   137.50 (-2.90%)
GOOGL   96.56 (-3.49%)
AMZN   114.49 (-2.98%)
TSLA   268.44 (-6.73%)
NVDA   120.84 (-5.12%)
NIO   15.61 (-9.92%)
BABA   78.29 (-3.33%)
AMD   63.88 (-6.55%)
T   15.51 (-2.02%)
MU   49.87 (-2.22%)
CGC   2.82 (-7.24%)
F   11.47 (-5.83%)
GE   62.35 (-3.27%)
DIS   97.07 (-2.34%)
AMC   7.09 (-7.56%)
PYPL   89.01 (-2.32%)
PFE   44.26 (-0.38%)
NFLX   239.03 (-2.52%)
NASDAQ:SHPH

Shuttle Pharmaceuticals - SHPH Stock Forecast, Price & News

$5.05
-0.51 (-9.17%)
(As of 09/29/2022 12:32 PM ET)
Add
Compare
Today's Range
$4.88
$5.43
50-Day Range
N/A
52-Week Range
$5.20
$126.26
Volume
4,862 shs
Average Volume
5.84 million shs
Market Capitalization
$67.06 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
SHPH stock logo

About Shuttle Pharmaceuticals (NASDAQ:SHPH) Stock

Shuttle Pharmaceuticals Holdings, Inc., through its subsidiary, Shuttle Pharmaceuticals, Inc., focuses on the discovery, development, and commercialization of drugs for sensitizing cancers to radiation therapy. Its products in clinical stage include Ropidoxuridine, an oral halogenated pyrimidine to treat patients with brain tumors and soft tissue sarcomas; and Doranidazole, an injectable hypoxic cell radiation sensitizer for treatment of pancreatic, lung, and liver cancers. The company was founded in 2012 and is based in Rockville, Maryland.

Receive SHPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Shuttle Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

SHPH Stock News Headlines

See More Headlines
Receive SHPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Shuttle Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

SHPH Company Calendar

Today
9/29/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:SHPH
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Market Cap
$67.06 million
Optionable
Not Optionable
Beta
N/A

Key Executives

  • Dr. Anatoly Dritschilo M.D. (Age 78)
    Co-Founder, CEO & Chairman
    Comp: $18.83k
  • Mr. Peter Dale Dritschilo M.B.A. (Age 53)
    M.D., Pres & COO
    Comp: $31.53k
  • Mr. Michael P. Vander Hoek (Age 62)
    CFO & VP of Operations and Regulatory
    Comp: $18.34k
  • Mr. Milton Brown M.D. (Age 57)
    Ph.D., Co-Founder, Chief Scientific Officer for Chemistry & Director
  • Dr. Mira Jung Ph.D. (Age 73)
    Co-Founder, Chief Scientific Officer for Biology
  • Mr. Gene Jung Esq.
    Gen. Counsel
  • Dr. Tyvin A. Rich M.D. (Age 73)
    Chief Medical Officer
  • Dr. Theodore L. Phillips M.D. (Age 89)
    Ph.D., Clinical Director
  • Mr. Michael Jeffrey Starkweather (Age 38)
    VP of Bus. Devel.













SHPH Stock - Frequently Asked Questions

How have SHPH shares performed in 2022?

Shuttle Pharmaceuticals' stock was trading at $38.80 on January 1st, 2022. Since then, SHPH stock has decreased by 85.7% and is now trading at $5.56.
View the best growth stocks for 2022 here
.

When did Shuttle Pharmaceuticals IPO?

(SHPH) raised $10 million in an IPO on Wednesday, August 31st 2022. The company issued 1,225,888 shares at $8.13 per share.

What is Shuttle Pharmaceuticals' stock symbol?

Shuttle Pharmaceuticals trades on the NASDAQ under the ticker symbol "SHPH."

How do I buy shares of Shuttle Pharmaceuticals?

Shares of SHPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Shuttle Pharmaceuticals' stock price today?

One share of SHPH stock can currently be purchased for approximately $5.56.

How much money does Shuttle Pharmaceuticals make?

Shuttle Pharmaceuticals (NASDAQ:SHPH) has a market capitalization of $73.85 million.

How can I contact Shuttle Pharmaceuticals?

The official website for the company is www.shuttlepharma.com. The company can be reached via phone at 240 403 4212 or via email at shph@lythampartners.com.

This page (NASDAQ:SHPH) was last updated on 9/29/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.